We invite all Professionals meeting the conditions specified below to submit offers to expert advisory services in the field of preclinical development of innovative medicinal products for human use.
The tender is carried out:
- in connection with the implementation by the Ordering Party of the project entitled “Use of matrix metalloproteinase inhibitor to develop an innovative therapy of preventing the development of post-traumatic and post-stroke epilepsy” /POIR.01.01.01-00-0235/20-00/ within Measure 1.1. R&D projects of enterprises, Submeasure 1.1.1 Industrial research and development work implemented by enterprises, co-financed by the European Regional Development Fund.
- in accordance with the principle of competitiveness and is not a subject of public procurement regulated by the Public Procurement Law of 11 September 2019.
Bids should be submitted electronically to the following e-mail address: pricing_offers@pikralida.eu or via the competitiveness database as a response hereto, wither personally or by post (the date of receipt shall be considered binding) to the address of the Ordering Party.
Please note that the bids must be submitted by the 3rd of December 2021 until: 11:59 pm.
The request for proposal No. 40/2021 and templates of documents have been published in the Competitiveness Database: https://bazakonkurencyjnosci.funduszeeuropejskie.gov.pl/ogloszenia/81312
to download: